Article Details

Tiburio launches with $31M and clinical-stage drugs for rare endocrine diseases

Retrieved on: 2019-01-02 20:36:33

Tags for this article:

Click the tags to see associated articles and topics

Tiburio launches with $31M and clinical-stage drugs for rare endocrine diseases. View article details on hiswai:

Excerpt

<div>The series A, drawn from <b>New Enterprise Associates</b>, Longitude Capital, Lundbeckfond Ventures,and Alexandria Venture Investments, will also cover ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up